Predicted Trait | |
Reported Trait | Major depression |
Mapped Trait(s) | major depressive disorder (MONDO_0002009) |
Score Construction | |
PGS Name | MDD_0.001_Coleman_2020 |
Development Method | |
Name | PRSice |
Parameters | PRSice 2.1.0.beta; pThreshold = 0.001;--clump-kb 250;--clump-p 1; --clump-r2 0.1;--info-base INFO,0.9;--model add;--stat OR; Effect allele is A1 |
Variants | |
Original Genome Build | hg19 |
Number of Variants | 1,138 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGS000080 |
Citation (link to publication) | Coleman JRI et al. Mol Psychiatry (2020) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 431,394 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
Europe PMC: 29700475 |
[
|
European | PGC |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000564 | PSS000294| European Ancestry| 92,957 individuals |
PGS000080 | Coleman JRI et al. Mol Psychiatry (2020) |
Reported Trait: Major depressive disorder | OR: 1.179 | — | R²: 0.01485 Nagelkerke pseudo-R2 (increase when adding PRS to null model of covariates): 0.00785 |
batch, centre, genomic prinicipal components (x6) | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000294 | Participants completed an online follow-up questionnaire assessing common mental health disorders, including MDD symptoms. Phenotypes were derived from this questionnaire. Individuals with probable MDD met lifetime criteria based on their responses to questions derived from the Composite International Diagnostic Interview. We excluded cases if they self-reported diagnoses of schizophrenia, other psychoses, or bipolar disorder. Controls were excluded if they self-reported any mental illness, taking any drug with an antidepressant indication, or had been hospitalised with a mood disorder or met previously-defined criteria for a mood disorder. | — | [ ,
45.0 % Male samples |
Range = [46.0, 80.0] years | European | — | UKB | — |